Considering that α-synuclein positivity is associated with increased risk of subsequent diagnosis of PD and DLB, its detection might represent a potential prodromal marker of these neurodegenerative disorders and a precious target in the neuroprotective trials [156]. Here, SNCA is linked to Lewy body dementia.